Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants
Condition: Healthy
Interventions: Drug: ALS-008176; Drug: Placebo; Drug: Moxifloxacin
Sponsor: Alios Biopharma Inc.
Recruiting - verified January 2017
Interventions: Drug: ALS-008176; Drug: Placebo; Drug: Moxifloxacin
Sponsor: Alios Biopharma Inc.
Recruiting - verified January 2017
News Type: